T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (190)	8/18/2000 10:39:49 AM
From: BulbaMan	Read Replies (3) of 2243

How about adding SpectruMedix (SMDX) to the Trickle portfolio. It's a micro-micro-cap (market-cap about $5 million) with huge risk but lots of upside if their DNA sequencer works. Below is an excerpt from SMDX's 7/14/00 press release: "SpectruMedix is a U.S. company focused on the development of high-speed and high throughput DNA sequencing and genetic analysis instrumentation for the acquisition, analysis, and management of complex genetic information and high throughput screening, massive parallel capillary electrophoresis systems for drug discovery. The DNA sequencing and high throughput screening instrumentation were developed in part from research efforts conducted at the United States Department of Energy's Ames Laboratory, which is operated by Iowa State University's Institute for Physical Research and Technology. In addition, a result of initial research conducted at the University of Pennsylvania Medical Center in Philadelphia, the Company is involved in the development of instrumentation and methodology to rapidly and accurately diagnose all pulmonary diseases as well as assess and monitor pulmonary function in order to optimally treat such patients."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next